CTCAE 0 5 0 5 B-clinical_variable
Grade 6 11 6 11 I-clinical_variable
> 12 13 12 13 O
2 14 15 14 15 B-lower_bound
neuropathy 16 26 16 26 I-lower_bound

castrate 0 8 27 35 B-clinical_variable
serum 9 14 36 41 I-clinical_variable
level 15 20 42 47 I-clinical_variable
of 21 23 48 50 I-clinical_variable
testosterone 24 36 51 63 I-clinical_variable
of 37 39 64 66 O
≤ 40 41 67 68 O
50 42 44 69 71 B-lower_bound
ng 45 47 72 74 I-lower_bound
/ 47 48 74 75 I-lower_bound
dL 48 50 75 77 I-lower_bound
( 51 52 78 79 O
≤ 52 53 79 80 O
1.73 54 58 81 85 B-lower_bound
mmol 59 63 86 90 I-lower_bound
/ 63 64 90 91 I-lower_bound
L 64 65 91 92 I-lower_bound
) 65 66 92 93 O

concomitant 0 11 94 105 O
use 12 15 106 109 O
of 16 18 110 112 O
therapeutic 19 30 113 124 B-treatment
anticoagulation 31 46 125 140 I-treatment

history 0 7 141 148 O
of 8 10 149 151 O
bleeding 11 19 152 160 B-chronic_disease
disorder 20 28 161 169 I-chronic_disease

previously 0 10 170 180 O
treated 11 18 181 188 O
with 19 23 189 193 O
abiraterone 24 35 194 205 B-treatment
, 35 36 205 206 O
enzalutamide 37 49 207 219 B-treatment
alone 50 55 220 225 O
or 56 58 226 228 O
in 59 61 229 231 O
combination 62 73 232 243 O
AND 74 77 244 247 O
must 78 82 248 252 O
have 83 87 253 257 O
demonstrated 88 100 258 270 O
evidence 101 109 271 279 O
of 110 112 280 282 O
objective 113 122 283 292 O
progression 123 134 293 304 O
as 135 137 305 307 O
per 138 141 308 311 O
PCWG3 142 147 312 317 O
criteria 148 156 318 326 O

received 0 8 327 335 O
cytotoxic 9 18 336 345 B-treatment
chemotherapy 19 31 346 358 I-treatment
for 32 35 359 362 O
either 36 42 363 369 O
metastatic 43 53 370 380 O
HSPC 54 58 381 385 B-cancer
or 59 61 386 388 O
CRPC 62 66 389 393 B-cancer
within 67 73 394 400 O
the 74 77 401 404 O
last 78 82 405 409 B-upper_bound
12 83 85 410 412 I-upper_bound
weeks 86 91 413 418 I-upper_bound
or 92 94 419 421 O
other 95 100 422 427 O
investigational 101 116 428 443 O
agents 117 123 444 450 O
within 124 130 451 457 O
4 131 132 458 459 B-upper_bound
weeks 133 138 460 465 I-upper_bound

standard 0 8 466 474 O
of 9 11 475 477 O
care 12 16 478 482 O
androgen 17 25 483 491 B-treatment
deprivation 26 37 492 503 I-treatment
treatment 38 47 504 513 I-treatment

use 0 3 514 517 O
of 4 6 518 520 O
opiate 7 13 521 527 B-treatment
analgesics 14 24 528 538 I-treatment
for 25 28 539 542 O
prostate 29 37 543 551 B-cancer
cancer 38 44 552 558 I-cancer
pain 45 49 559 563 O
within 50 56 564 570 O
4 57 58 571 572 B-upper_bound
week 59 63 573 577 I-upper_bound
of 64 66 578 580 O
treatment 67 76 581 590 B-treatment
start 77 82 591 596 O

